242. Deputy Ken O'Flynn asked the Minister for Health whether standard cost-effectiveness thresholds applied by the National Centre for Pharmacoeconomics are adjusted in the case of rare diseases; if not, whether the Minister will consider reforming these thresholds to reflect the unique clinical and ethical context of low-prevalence conditions. [29081/26]

Summary

242. Deputy Ken O'Flynn asked the Minister for Health whether standard cost-effectiveness thresholds applied by the National Centre for Pharmacoeconomics are adjusted in the case of rare diseases; if not, whether the Minister will consider reforming these thresholds to reflect the unique clinical and ethical context of low-prevalence conditions. [29081/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Health Services

  xml · EN · 22 April 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.